Selected research
Market Structure
Global Anti-Infective Agents for Livestock Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Anti-Infective Agents for Livestock market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Anti-Infective Agents for Livestock is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anti-Infective Agents for Livestock is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-Infective Agents for Livestock is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Anti-Infective Agents for Livestock is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anti-Infective Agents for Livestock include Merck, Boehringer Ingelheim, Bayer, Zoetis, Virbac, Vetoquinol, Elanco, Chanelle and Ceva Sante Animale, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Anti-Infective Agents for Livestock market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-Infective Agents for Livestock and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-Infective Agents for Livestock sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-Infective Agents for Livestock market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-Infective Agents for Livestock Segment by Company
Merck
Boehringer Ingelheim
Bayer
Zoetis
Virbac
Vetoquinol
Elanco
Chanelle
Ceva Sante Animale
Bimeda Animal Health
Anti-Infective Agents for Livestock Segment by Type
External Use
Internal Use
Anti-Infective Agents for Livestock Segment by Application
Pigs
Sheep
Cattle
Other
Anti-Infective Agents for Livestock Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infective Agents for Livestock market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Infective Agents for Livestock and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infective Agents for Livestock.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anti-Infective Agents for Livestock market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Infective Agents for Livestock manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Infective Agents for Livestock in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Anti-Infective Agents for Livestock in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- External Use
- Internal Use
Applications
- Pigs
- Sheep
- Cattle
- Other
Companies covered
- Merck
- Boehringer Ingelheim
- Bayer
- Zoetis
- Virbac
- Vetoquinol
- Elanco
- Chanelle
- Ceva Sante Animale
- Bimeda Animal Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Anti-Infective Agents for Livestock Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Anti-Infective Agents for Livestock Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Anti-Infective Agents for Livestock Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Anti-Infective Agents for Livestock Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Anti-Infective Agents for Livestock Market Dynamics
- 2.1 Anti-Infective Agents for Livestock Industry Trends
- 2.2 Anti-Infective Agents for Livestock Industry Drivers
- 2.3 Anti-Infective Agents for Livestock Industry Opportunities and Challenges
- 2.4 Anti-Infective Agents for Livestock Industry Restraints
3 Anti-Infective Agents for Livestock Market by Manufacturers
- 3.1 Global Anti-Infective Agents for Livestock Revenue by Manufacturers (2021-2026)
- 3.2 Global Anti-Infective Agents for Livestock Sales by Manufacturers (2021-2026)
- 3.3 Global Anti-Infective Agents for Livestock Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Anti-Infective Agents for Livestock Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Anti-Infective Agents for Livestock Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Anti-Infective Agents for Livestock Manufacturers, Product Type & Application
- 3.7 Global Anti-Infective Agents for Livestock Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Anti-Infective Agents for Livestock Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Anti-Infective Agents for Livestock Players Market Share by Revenue in 2025
- 3.8.3 2025 Anti-Infective Agents for Livestock Tier 1, Tier 2, and Tier 3
4 Anti-Infective Agents for Livestock Market by Type
- 4.1 Anti-Infective Agents for Livestock Type Introduction
- 4.1.1 External Use
- 4.1.2 Internal Use
- 4.2 Global Anti-Infective Agents for Livestock Sales by Type
- 4.2.1 Global Anti-Infective Agents for Livestock Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Anti-Infective Agents for Livestock Sales by Type (2021-2032)
- 4.2.3 Global Anti-Infective Agents for Livestock Sales Market Share by Type (2021-2032)
- 4.3 Global Anti-Infective Agents for Livestock Revenue by Type
- 4.3.1 Global Anti-Infective Agents for Livestock Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Anti-Infective Agents for Livestock Revenue by Type (2021-2032)
- 4.3.3 Global Anti-Infective Agents for Livestock Revenue Market Share by Type (2021-2032)
5 Anti-Infective Agents for Livestock Market by Application
- 5.1 Anti-Infective Agents for Livestock Application Introduction
- 5.1.1 Pigs
- 5.1.2 Sheep
- 5.1.3 Cattle
- 5.1.4 Other
- 5.2 Global Anti-Infective Agents for Livestock Sales by Application
- 5.2.1 Global Anti-Infective Agents for Livestock Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Anti-Infective Agents for Livestock Sales by Application (2021-2032)
- 5.2.3 Global Anti-Infective Agents for Livestock Sales Market Share by Application (2021-2032)
- 5.3 Global Anti-Infective Agents for Livestock Revenue by Application
- 5.3.1 Global Anti-Infective Agents for Livestock Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Anti-Infective Agents for Livestock Revenue by Application (2021-2032)
- 5.3.3 Global Anti-Infective Agents for Livestock Revenue Market Share by Application (2021-2032)
6 Global Anti-Infective Agents for Livestock Sales by Region
- 6.1 Global Anti-Infective Agents for Livestock Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Anti-Infective Agents for Livestock Sales by Region (2021-2032)
- 6.2.1 Global Anti-Infective Agents for Livestock Sales by Region (2021-2026)
- 6.2.2 Global Anti-Infective Agents for Livestock Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Anti-Infective Agents for Livestock Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Anti-Infective Agents for Livestock Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Anti-Infective Agents for Livestock Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Anti-Infective Agents for Livestock Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Anti-Infective Agents for Livestock Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Anti-Infective Agents for Livestock Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Anti-Infective Agents for Livestock Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Anti-Infective Agents for Livestock Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Anti-Infective Agents for Livestock Revenue by Region
- 7.1 Global Anti-Infective Agents for Livestock Revenue by Region
- 7.1.1 Global Anti-Infective Agents for Livestock Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Anti-Infective Agents for Livestock Revenue by Region (2021-2026)
- 7.1.3 Global Anti-Infective Agents for Livestock Revenue by Region (2027-2032)
- 7.1.4 Global Anti-Infective Agents for Livestock Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Anti-Infective Agents for Livestock Revenue (2021-2032)
- 7.2.2 North America Anti-Infective Agents for Livestock Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Anti-Infective Agents for Livestock Revenue (2021-2032)
- 7.3.2 Europe Anti-Infective Agents for Livestock Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Anti-Infective Agents for Livestock Revenue (2021-2032)
- 7.4.2 Asia-Pacific Anti-Infective Agents for Livestock Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Anti-Infective Agents for Livestock Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Anti-Infective Agents for Livestock Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Company Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck Anti-Infective Agents for Livestock Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Merck Anti-Infective Agents for Livestock Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Boehringer Ingelheim
- 8.2.1 Boehringer Ingelheim Company Information
- 8.2.2 Boehringer Ingelheim Business Overview
- 8.2.3 Boehringer Ingelheim Anti-Infective Agents for Livestock Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Boehringer Ingelheim Anti-Infective Agents for Livestock Product Portfolio
- 8.2.5 Boehringer Ingelheim Recent Developments
- 8.3 Bayer
- 8.3.1 Bayer Company Information
- 8.3.2 Bayer Business Overview
- 8.3.3 Bayer Anti-Infective Agents for Livestock Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bayer Anti-Infective Agents for Livestock Product Portfolio
- 8.3.5 Bayer Recent Developments
- 8.4 Zoetis
- 8.4.1 Zoetis Company Information
- 8.4.2 Zoetis Business Overview
- 8.4.3 Zoetis Anti-Infective Agents for Livestock Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Zoetis Anti-Infective Agents for Livestock Product Portfolio
- 8.4.5 Zoetis Recent Developments
- 8.5 Virbac
- 8.5.1 Virbac Company Information
- 8.5.2 Virbac Business Overview
- 8.5.3 Virbac Anti-Infective Agents for Livestock Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Virbac Anti-Infective Agents for Livestock Product Portfolio
- 8.5.5 Virbac Recent Developments
- 8.6 Vetoquinol
- 8.6.1 Vetoquinol Company Information
- 8.6.2 Vetoquinol Business Overview
- 8.6.3 Vetoquinol Anti-Infective Agents for Livestock Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Vetoquinol Anti-Infective Agents for Livestock Product Portfolio
- 8.6.5 Vetoquinol Recent Developments
- 8.7 Elanco
- 8.7.1 Elanco Company Information
- 8.7.2 Elanco Business Overview
- 8.7.3 Elanco Anti-Infective Agents for Livestock Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Elanco Anti-Infective Agents for Livestock Product Portfolio
- 8.7.5 Elanco Recent Developments
- 8.8 Chanelle
- 8.8.1 Chanelle Company Information
- 8.8.2 Chanelle Business Overview
- 8.8.3 Chanelle Anti-Infective Agents for Livestock Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Chanelle Anti-Infective Agents for Livestock Product Portfolio
- 8.8.5 Chanelle Recent Developments
- 8.9 Ceva Sante Animale
- 8.9.1 Ceva Sante Animale Company Information
- 8.9.2 Ceva Sante Animale Business Overview
- 8.9.3 Ceva Sante Animale Anti-Infective Agents for Livestock Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Ceva Sante Animale Anti-Infective Agents for Livestock Product Portfolio
- 8.9.5 Ceva Sante Animale Recent Developments
- 8.10 Bimeda Animal Health
- 8.10.1 Bimeda Animal Health Company Information
- 8.10.2 Bimeda Animal Health Business Overview
- 8.10.3 Bimeda Animal Health Anti-Infective Agents for Livestock Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Bimeda Animal Health Anti-Infective Agents for Livestock Product Portfolio
- 8.10.5 Bimeda Animal Health Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Anti-Infective Agents for Livestock Value Chain Analysis
- 9.1.1 Anti-Infective Agents for Livestock Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Anti-Infective Agents for Livestock Production Mode & Process
- 9.2 Anti-Infective Agents for Livestock Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Anti-Infective Agents for Livestock Distributors
- 9.2.3 Anti-Infective Agents for Livestock Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst